Eocene Ltd. (EOCN)
3.54
-0.08
(-2.21%)
USD |
NASDAQ |
Oct 09, 16:00
3.51
-0.03
(-0.85%)
After-Hours: 20:00
Eocene Price : 3.54 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 09, 2026 | 3.46 | 3.60 | 3.46 | 3.54 | 5975.00 |
| Oct 08, 2026 | 3.61 | 3.63 | 3.42 | 3.62 | 14797.00 |
| Oct 07, 2026 | 3.49 | 3.63 | 3.35 | 3.458 | 13527.00 |
| Oct 06, 2026 | 3.45 | 3.563 | 3.28 | 3.36 | 10180.00 |
| Oct 05, 2026 | 3.55 | 3.62 | 3.450 | 3.450 | 7671.00 |
| Oct 02, 2026 | 3.326 | 3.62 | 3.26 | 3.61 | 4850.00 |
| Oct 01, 2026 | 3.14 | 3.62 | 3.12 | 3.405 | 12577.00 |
| Sep 30, 2026 | 3.45 | 3.49 | 3.39 | 3.49 | 2602.00 |
| Sep 29, 2026 | 3.595 | 3.63 | 3.50 | 3.55 | 5635.00 |
| Sep 28, 2026 | 3.460 | 3.63 | 3.460 | 3.63 | 3889.00 |
| Sep 25, 2026 | 3.62 | 3.800 | 3.56 | 3.63 | 3682.00 |
| Sep 24, 2026 | 3.752 | 3.752 | 3.62 | 3.62 | 2963.00 |
| Sep 23, 2026 | 3.47 | 3.65 | 3.46 | 3.62 | 5356.00 |
| Sep 22, 2026 | 3.67 | 3.800 | 3.45 | 3.625 | 15767.00 |
| Sep 21, 2026 | 3.33 | 3.66 | 3.33 | 3.50 | 3493.00 |
| Sep 18, 2026 | 3.47 | 3.60 | 3.346 | 3.37 | 8492.00 |
| Sep 17, 2026 | 3.48 | 3.92 | 3.267 | 3.48 | 14190.00 |
| Sep 16, 2026 | 3.50 | 3.65 | 3.39 | 3.41 | 10562.00 |
| Sep 15, 2026 | 3.58 | 3.75 | 3.50 | 3.625 | 14002.00 |
| Sep 14, 2026 | 3.72 | 3.89 | 3.503 | 3.82 | 10607.00 |
| Sep 11, 2026 | 4.00 | 4.220 | 3.655 | 3.84 | 44885.00 |
| Sep 10, 2026 | 4.28 | 4.88 | 3.89 | 4.03 | 192001.0 |
| Sep 09, 2026 | 3.91 | 4.63 | 3.82 | 4.63 | 303322.0 |
| Sep 08, 2026 | 3.81 | 3.96 | 3.74 | 3.825 | 14847.00 |
| Sep 04, 2026 | 4.075 | 4.23 | 3.88 | 3.88 | 4100.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| BioLineRx Ltd. | 2.216 |
| XTL Biopharmaceuticals Ltd. | 1.98 |
| Kamada Ltd. | 8.08 |
| Can-Fite BioPharma Ltd. | 1.90 |
| Revium Recovery, Inc. | 1.43 |
Price Related Metrics
| Price to Book Value | 0.2783 |
| Earnings Yield | -390.0% |
| Market Cap | 3.545M |